key: cord-0688398-i8g9y5qm
authors: Park, Simon S.
title: Post-Glycosylation Modification of Sialic Acid and Its Role in Virus Pathogenesis
date: 2019-11-01
journal: Vaccines (Basel)
DOI: 10.3390/vaccines7040171
sha: 22450e467873a3cf4f2627d36d6f71aa779520c4
doc_id: 688398
cord_uid: i8g9y5qm

Sialic acids are a family of nine carbon keto-aldononulosonic acids presented at the terminal ends of glycans on cellular membranes. α-Linked sialoglycoconjugates often undergo post-glycosylation modifications, among which O-acetylation of N-acetyl neuraminic acid (Neu5Ac) is the most common in mammalian cells. Isoforms of sialic acid are critical determinants of virus pathogenesis. To date, the focus of viral receptor-mediated attachment has been on Neu5Ac. O-Acetylated Neu5Acs have been largely ignored as receptor determinants of virus pathogenesis, although it is ubiquitous across species. Significantly, the array of structures resulting from site-specific O-acetylation by sialic acid O-acetyltransferases (SOATs) provides a means to examine specificity of viral binding to host cells. Specifically, C(4) O-acetylated Neu5Ac can influence virus pathogenicity. However, the biological implications of only O-acetylated Neu5Ac at C(7–9) have been explored extensively. This review will highlight the biological significance, extraction methods, and synthetic modifications of C(4) O-acetylated Neu5Ac that may provide value in therapeutic developments and targets to prevent virus related diseases.

The discovery of sialic acid [1] from bovine submaxillary mucin in 1936 gave the first glance to a unique family of sugars that play important roles in a wide array of biological functions. Currently, sialic acid (Sia) refers to a family of more than 50 forms typically varying at the C 5 position (Figure 1 ). Chief among these in mammalian cells [2] is N-acetyl neuraminic acid (Neu5Ac), which is a keto-aldononulosonic acid positioned at the terminal ends of glycolipids and glycoproteins [3] .

The discovery of sialic acid [1] from bovine submaxillary mucin in 1936 gave the first glance to a unique family of sugars that play important roles in a wide array of biological functions. Currently, sialic acid (Sia) refers to a family of more than 50 forms typically varying at the C5 position ( Figure  1 ). Chief among these in mammalian cells [2] is N-acetyl neuraminic acid (Neu5Ac), which is a ketoaldononulosonic acid positioned at the terminal ends of glycolipids and glycoproteins [3] . O-Acetylation of Neu5Ac by SOATs is site-specific and biological functions are based on the position of acetyl groups. Much of the focus has revolved around O-acetylation at the C7, 8 , and 9 positions of Neu5Ac due to high abundance across species [15] [16] [17] , although C4-O-acetylated Neu5Ac has garnered more attention recently in the context of virus binding [30] . Table 1 . Select examples of O-acetylated Neu5Ac found in Nature [12] . O-Acetyl migration in bacterial systems, however, is more promiscuous and less predictable. Regarding N. meningitidis, acetyl migration of Type C polysaccharide occurs from C 8 to C 7 when monitored by 1 H and 13 C NMR [26, 27] , while acetyl groups of serogroup W-135 polysaccharides containing α-(2,6)-linkages to galactose or glucose spontaneously migrate from C 7 to C 9 [28] . As a result, it was believed that C 9 O-acetylated Neu5Ac is a product of acetyl migration, although Varki and co-workers speculated that sialoglycoconjugates in the Golgi may be O-acetylated exclusively at C 7 and C 9 by different SOATs [29] . More recently, Gilbert and co-workers supported the idea, through 1D and 2D NMR studies, that SOATs identified from C. jejuni can exclusively O-acetylate at the C 9 hydroxyl group [18] . These studies suggest that acetyl migrations between proximal hydroxyl groups at C 7 (or C 8 ) and C 9 appear to be spontaneous while the O-acetyl group at C 4 remains unaffected.

O-Acetylation of Neu5Ac by SOATs is site-specific and biological functions are based on the position of acetyl groups. Much of the focus has revolved around O-acetylation at the C 7, 8, and 9 positions of Neu5Ac due to high abundance across species [15] [16] [17] , although C 4 -O-acetylated Neu5Ac has garnered more attention recently in the context of virus binding [30] . Table 1 . Select examples of O-acetylated Neu5Ac found in Nature [12] .

Occurrence a During viral infection, viral glycoproteins recognize Sia as receptor determinants to prompt entry and exit from the host cell [30] . Seen in certain virus species, recognition of sialoglycoconjugates with defined linkages and isoforms is apparent [33] . Hemagglutinin (HA) of influenza A and B viruses, for example, utilize α-2,3-linked sialoglycoconjugates for attachment [34, 35] , while hemagglutinin-neuraminidase glycoprotein of respirovirus can utilize α-2,6-linked sialoglycoconjugates for attachment. Meanwhile, coronaviruses, a positive-sense single stranded RNA virus classified under the family Coronaviridae, contain spike (S) glycoproteins (and hemagglutinin-esterases) that utilize O-acetyl forms of Sia for attachment [36] [37] [38] . Viral fusion with the host membrane promotes viral replication and release is dictated by receptor-destroying enzymes including sialidase (or neuraminidase) or hemagglutinin-esterases, depending on the virus type [30] . Viral pathogenicity, therefore, requires a specific host-receptor partnership. It was believed that Sia glycosylation patterns were the most critical features to virus binding; however, recognition of modified Sia appears to be equally important. More specifically, O-acetylation at varying sites of Sia (i.e. C 4 vs. C 7-9 ) influences virus recognition and attachment. Viral receptor molecules show remarkable specificity toward host sialic acid isoforms at a molecular level and delving deeper into the 

-4-O-acetylneuraminic acid V 5-N-Acetyl-7-O-acetylneuraminic acid V, Pz, B 5-N-Acetyl-8-O-acetylneuraminic acid V, B 5-N-Acetyl-9-O-acetylneuraminic acid V, E, Pz, F, B, H [31] 5-N-Acetyl-4,9-di-O-acetylneuraminic acid V 5-N-Acetyl-7,9-di-O-acetylneuraminic acid V, B, H [32] 5-N-Acetyl-8,9-di-O-acetylneuraminic acid V, H [32] 5-N-Acetyl-4,7,9-tri-O-acetylneuraminic acid V 5-N-Acetyl-7,8,9-tri-O-acetylneuraminic acid

Site-specific O-acetylated sialoglycoconjugates are found across a variety of species. C 9 O-acetylated Neu5Acs, for instance, are found in the human gut ranging from 14-23% ( Figure 3 ) [12, 39] . Meanwhile, C 4 O-acetylated Neu5Ac is ubiquitous in ungulates [11, 22, [40] [41] [42] [43] [44] , echinoderms [45] , Australian monotreme echidna [40] , and a subgroup of chordates [42] [43] [44] 46, 47] . Among several vertebrates, C 4 -O-acetylated Neu5Ac was found mostly in the circulatory system of fish [47] .

including sialidase (or neuraminidase) or hemagglutinin-esterases, depending on the virus type [30] . Viral pathogenicity, therefore, requires a specific host-receptor partnership. It was believed that Sia glycosylation patterns were the most critical features to virus binding; however, recognition of modified Sia appears to be equally important. More specifically, O-acetylation at varying sites of Sia (i.e. C4 vs C7-9) influences virus recognition and attachment. Viral receptor molecules show remarkable specificity toward host sialic acid isoforms at a molecular level and delving deeper into the effects of O-acetylated Sia/viral enzymes may help identify a potential therapeutic target to prevent virus-related diseases.

Site-specific O-acetylated sialoglycoconjugates are found across a variety of species. C9 Oacetylated Neu5Acs, for instance, are found in the human gut ranging from 14-23% ( Figure 3 ) [12, 39] .

Meanwhile, C4 O-acetylated Neu5Ac is ubiquitous in ungulates [11, 22, [40] [41] [42] [43] [44] , echinoderms [45] , Australian monotreme echidna [40] , and a subgroup of chordates [42] [43] [44] 46, 47] . Among several vertebrates, C4-O-acetylated Neu5Ac was found mostly in the circulatory system of fish [47] . Enzymatic or mildly acidic hydrolytic release from mucins are conventional methods by which partially O-acetylated Neu5Ac have been extracted prior to characterization [48] [49] [50] . The most convenient isolation techniques involve the application of sialidases; however, issues related to manufacturing costs and activities without jeopardizing the integrity of O-acetyl groups prevent access to materials at a commercial scale.

Among detection strategies, histochemical staining has become a widely accepted technique for detecting O-acetylated Neu5Ac with information on site-specificity (Table 2 ). Ravindranaths and coworkers, for instance, showed that radiolabeled, purified crab lectin from Cancer antennarius incubated with erythrocytes in Tris buffered saline bound to C9 O-acetylated Neu5Ac using radiolabelled assays [51] . More recently, advances in using matrix-assisted laser desorption/ionization mass spectrometry (MALDI) combined with imaging software have enabled mapping of the localization of O-acetylation on gangliosides [52, 53] . Furthermore, modern techniques available for analyses include fluorescence detection by 1,2-diamino-4,5methylenedioxybenzene [54] , Neu5Ac analogs using high-performance liquid chromatography [55] [56] [57] , colorimetric determination [58] [59] [60] , thin-layer chromatography [60] , electrospray-ionization mass spectrometry [61] , GC-MS of silylated analogues [62] , and NMR [53, 63] . Enzymatic or mildly acidic hydrolytic release from mucins are conventional methods by which partially O-acetylated Neu5Ac have been extracted prior to characterization [48] [49] [50] . The most convenient isolation techniques involve the application of sialidases; however, issues related to manufacturing costs and activities without jeopardizing the integrity of O-acetyl groups prevent access to materials at a commercial scale.

Among detection strategies, histochemical staining has become a widely accepted technique for detecting O-acetylated Neu5Ac with information on site-specificity (Table 2 ). Ravindranaths and co-workers, for instance, showed that radiolabeled, purified crab lectin from Cancer antennarius incubated with erythrocytes in Tris buffered saline bound to C 9 O-acetylated Neu5Ac using radiolabelled assays [51] . More recently, advances in using matrix-assisted laser desorption/ionization mass spectrometry (MALDI) combined with imaging software have enabled mapping of the localization of O-acetylation on gangliosides [52, 53] . Furthermore, modern techniques available for analyses include fluorescence detection by 1,2-diamino-4,5-methylenedioxybenzene [54] , Neu5Ac analogs using high-performance liquid chromatography [55] [56] [57] , colorimetric determination [58] [59] [60] , thin-layer chromatography [60] , electrospray-ionization mass spectrometry [61] , GC-MS of silylated analogues [62] , and NMR [53, 63] . 

To the capsular polysaccharide (CPS) of Streptococcus suis that is responsible for causing meningitis, Jin and co-workers found that partially O-acetylated CMP Neu5Ac (e.g., Neu5,7 (8, 9) Ac 2 ) are used as glycosyl donors rather than free CMP sialic acid [99] . Several strains of Gram-negative bacteria, such as S. suis, E. coli, S. agalactiae, modulate CPS by a bifunctional genetic code, NeuA, which encodes for CMP-Neu5Ac synthetase/O-acetylesterase activities (Figure 4 ). The reasons for which the bacteria utilize partially O-acetylated Neu5Ac as a substrate for CMP synthetase (CSS), only to be de-O-acetylated, are still under investigation. Nonetheless, this study suggests that O-acetylation of Neu5Ac is not exclusive to post-glycosylation modification. Rather, it can be used directly as substrates for glycosylation, although only the O-acetylated forms at the C 7-9 were investigated. More recently, the Chen group demonstrated the feasibility of C 4 O-acetylated Neu5Ac as substrates for CMP activation [100] using CSS from Neisseria meningitidis and mutants, Pasteurella multocida, and Haemophilus ducreyi. Upon CMP activation, PmST3 sialyltransferase was able to uptake CMP Neu4,5Ac 2 to render α-2,3 linked sialoglycoconjugates without compromising the acetyl group. 

To the capsular polysaccharide (CPS) of Streptococcus suis that is responsible for causing meningitis, Jin and co-workers found that partially O-acetylated CMP Neu5Ac (e.g. Neu5,7 (8, 9) Ac2) are used as glycosyl donors rather than free CMP sialic acid [99] . Several strains of Gram-negative bacteria, such as S. suis, E. coli, S. agalactiae, modulate CPS by a bifunctional genetic code, NeuA, which encodes for CMP-Neu5Ac synthetase/O-acetylesterase activities (Figure 4 ). The reasons for which the bacteria utilize partially O-acetylated Neu5Ac as a substrate for CMP synthetase (CSS), only to be de-O-acetylated, are still under investigation. Nonetheless, this study suggests that Oacetylation of Neu5Ac is not exclusive to post-glycosylation modification. Rather, it can be used directly as substrates for glycosylation, although only the O-acetylated forms at the C7-9 were investigated. More recently, the Chen group demonstrated the feasibility of C4 O-acetylated Neu5Ac as substrates for CMP activation [100] using CSS from Neisseria meningitidis and mutants, Pasteurella multocida, and Haemophilus ducreyi. Upon CMP activation, PmST3 sialyltransferase was able to uptake CMP Neu4,5Ac2 to render -2,3 linked sialoglycoconjugates without compromising the acetyl group. Considering eukaryotic systems, O-acetylated Neu5Acs of colonic mucin glycoproteins from human colon cell lines are ubiquitous [37] . Corfield and co-workers showed the inhibition of B. bifidum VIII-210 sialidase activity by C7,8, and 9 O-acetylated Neu5Ac [101] in 1992. Interestingly, the inhibitory effects were increased as amounts of O-acetyl groups increased. When di-O-acetylated Neu5,7,9Ac3 was incubated with bacterial sialidases, sialic acid cleavage decreased two-fold compared to mono O-acetylated forms. Saponification conditions that de-O-acetylate led to an increase of released sialic acid by sialidases, which suggests that the presence of O-acetyl groups inhibits bacterial sialidase activities, although it remains unclear whether C4 O-acetylation exhibits similar functions.

Since the discovery of O-acetylated Neu5Ac by Blix and co-workers [102] , Pepper reported the effects of O-acetylated Neu5Ac on virus hemagglutinin/neuraminidase activities [103] . Concerning horse serum, C4-O-acetylated Neu5Ac accounts for approximately 50% of the total sialylation, as confirmed by structural elucidation using thin-layer chromatography, gas chromatography, and periodate oxidation. These studies revealed that the C4-O-acetylated Neu5Ac, found exclusively on 2-macroglubulin, inhibits hemagglutinin of the influenza A2 strain. Treatment with NaOH or NaIO4 gave slow to complete loss of hemagglutinin inhibition, presumably due to the loss of the C4 O-acetyl Considering eukaryotic systems, O-acetylated Neu5Acs of colonic mucin glycoproteins from human colon cell lines are ubiquitous [37] . Corfield and co-workers showed the inhibition of B. bifidum VIII-210 sialidase activity by C 7,8, and 9 O-acetylated Neu5Ac [101] in 1992. Interestingly, the inhibitory effects were increased as amounts of O-acetyl groups increased. When di-O-acetylated Neu5,7,9Ac 3 was incubated with bacterial sialidases, sialic acid cleavage decreased two-fold compared to mono O-acetylated forms. Saponification conditions that de-O-acetylate led to an increase of released sialic acid by sialidases, which suggests that the presence of O-acetyl groups inhibits bacterial sialidase activities, although it remains unclear whether C 4 O-acetylation exhibits similar functions.

Since the discovery of O-acetylated Neu5Ac by Blix and co-workers [102] , Pepper reported the effects of O-acetylated Neu5Ac on virus hemagglutinin/neuraminidase activities [103] . Concerning horse serum, C 4 -O-acetylated Neu5Ac accounts for approximately 50% of the total sialylation, as confirmed by structural elucidation using thin-layer chromatography, gas chromatography, and periodate oxidation. These studies revealed that the C 4 -O-acetylated Neu5Ac, found exclusively on α 2 -macroglubulin, inhibits hemagglutinin of the influenza A2 strain. Treatment with NaOH or NaIO 4 gave slow to complete loss of hemagglutinin inhibition, presumably due to the loss of the C 4 O-acetyl group [16, 103] . Furthermore, Pepper was one of the first to demonstrate selective reactions to viral or bacterial neuraminidases by C 4 -O-acetylated Neu5Ac. This was a significant finding since it indicated that O-acetylated Sia determinants provide specific function (Table 3) . Added to the inhibitory effects of C 4 -O-acetylated Neu5Ac, it also has been implicated in facilitating the initial attachment of viruses to target cells. Similar to influenza C virus, infectious salmon anemia virus (ISAV) is classified under the Orthomyxoviridae family and contains spike glycoproteins hemagglutinin-esterase (HE) and fusion (HEF) proteins that mediate virus entry and exit. HE exhibits hemagglutination and receptor destroying activities and C 4 -O-acetylated Neu5Ac was defined as the major receptor determinant [81] . While influenza C virus recognizes C 9 -O-acetylated Neu5Ac, ISAV is selective for C 4 -O-acetylated Neu5Ac in receptor binding and destroying activities, despite known similarities to influenza C virus HE [51] .

The receptor destroying enzyme displays acetylesterase activity and can cleave O-acetyl groups with high specificity. Regarding the case of ISAV, C 4 -O-acetyl was cleaved via 4-sialyl-O-acetylesterase with high turnover rates, while de-O-acetylation of C 9 -O-acetylated Neu5Ac required substantially extended incubation times. Furthermore, abolishment of hemagglutination inhibition was observed when guinea pig and horse sera were subjected to saponification conditions (e.g., 0.1 N NaOH) while rat serum exhibited no effects. Significantly, these studies provide evidence of molecular specificity depending on the position of acetyl groups (C 4 vs. C 9 ) and highlight the importance of enzymes that mediate these functions, which appear to be tailored to specific O-acetyl expression profiles of Sia.

Seen in another case, toro-and corona-viruses of the Coronaviridae family display remarkable receptor binding specificity to O-acetylated Sia determinants. These viruses contain S and HE glycoproteins that mediate virus entry and exit. Similar to influenza C virus HEF, murine coronaviruses display HE activities consistent with the observation that this enzyme was acquired via horizontal gene transfer [136] . Thus, most of the murine coronavirus HEs recognize C 9 -O-acetylated Neu5Ac as Sia determinants; however, a subset of murine coronavirus HE failed to recognize C 4 -O-acetylated Neu5Ac. Specifically, HE of the mouse hepatitis virus (MHV) DVIM-strain recognizes C 9 -O-acetylated Neu5Ac, while HE of the MHV S-strain evolved to display strong binding preference toward C 4 -O-acetylated Neu5Ac ligand [83, 85, 140, 141] . The crystal structure of MHV DVIM-HE closely resembles the overall architecture of coronavirus-Mebus (BCoV-Mebus) HE that favors C 9 -O-acetylated Neu5Ac as the binding ligand. While the R1-, R2-, and E-loops of MHV S-HE resemble BCov-Mebus HE, changes to the R3-and R4-loops are responsible for presenting preferential binding to one O-acetyl Sia form over another. Specifically, the hydrophobic pocket that once accommodated the C 5 Nand C 9 O-acetyl groups of Neu5Ac is mutated to accommodate the C 5 Nand C 4 -O-acetyl groups of Neu5Ac. This conformational shift is responsible primarily for the change in the receptor specificity of MHV Sand DVIM-strains, although the reasons for such changes between distinct MHV lineages remain ambiguous [36, 136] . The authors propose that evolutionary changes to accommodate the receptors that once remained neutral indicate plasticity of HE, which may lead to resistance against treatments.

Inhibition of sialidase activity by modified Sia also is involved in non-virus mediated phenomena. As a mechanism for survival, milk serves as a source of nutrients and bioactive components for offspring during early development; however, platypuses secrete milk through their skin, which poses a high risk for pathogenic infections [51] . Thus, platypuses produce O-acetylated Sia in elevated amounts, a variant of sialic acid shown to interfere with recognition by mammalian and bacterial sialidases. When glycoforms of Tasmanian echidna and platypus milk pools were analyzed [126] , the milk oligosaccharides were found to be abundant in C 4 -O-acetylated sialyllactose, such that it comprised the majority of acidic oligosaccharides. Given that sialidase activity is inhibited by C 4 -O-acetylated Neu5Ac [129] , the authors suggest that platypuses adopted this defensive strategy to counter-measure pathogenic mediated catabolism.

Site-specific O-acetylation of Sia imparts selective biological functions. Certain neuraminidases and/or esterase activities recognize O-acetyl groups on the C 4 of Sia, but not at other positions. The presence of an acetyl group provides added sterics to block bacterial neuraminidases [103] , while viral neuraminidase activities remain unaltered. These examples highlight the potential of modifying certain positions of Sia to induce a specific function. Von-Itzstein and co-workers developed in 1993 a rationally designed inhibitor against sialidases of influenza A and B viruses [142] . Aided by the X-ray crystallography and GRID calculations, it was determined that C 4 substitution by a basic functional group would form a favorable interaction with Glu 119 in the active site. Given that sialidases bind to Sia in the boat conformation, modified Sia in the C 2 -C 3 unsaturated form (Neu5Ac2en), bearing a guanidine group at the C 4 , inhibited sialidases of influenza A virus (Singapore/1/57) and B virus (Victoria/102/85) with IC 50 values of 14 nM and 5 nM, respectively. This work was extended to inhibit sialidases of the human parainfluenza virus (hPIV) type 3 [143] . hPIV is classified under the family Paramyxoviridae that contains HN and fusion proteins. An X-ray crystal structure was deduced and the revelation of a hollow region near the C 4 of Neu5Ac2en led to substituting various alkyl groups at the C 4 . Consequently, the O-ethyl group gave the best IC 50 value of 3 µM, while zanamivir that contains the 4-guanidino group also inhibited hPIV-3 (strain C243) sialidases with an IC 50 value of 25 µM. This further validates that inhibition of sialidases responds to specific groups of Neu5Ac2en at the C 4 that have been rationally designed. Consistent with findings by Pepper [103] , sialidase response to treatment appeared to be selective across species. These findings ultimately led to the development of oseltamivir (tradename Tamiflu, Basel, Switzerland) and zanamivir (tradename Relenza, London, UK) [144] . However, adverse effects and low efficacy led to decreased clinical use. Thus, efforts to develop inhibitors of sialidase as a therapeutic target are being investigated actively.

Current extraction methods give inadequate yields; thus, synthetic efforts to obtain O-acetylated Sias in pure form are valuable. Using a conventional synthetic approach, a series of mono-O-acetylated Neu5Ac have been synthesized, including Neu4,5Ac 2 , Neu5,8Ac 2 , Neu2,5Ac 2 , Neu5,7Ac 2 [110] . These conjugates were synthesized in pure, monomeric forms without acetyl migrations or anomerization; thus, they serve as useful standards for delving deeper into studies related to partially O-acetylated Neu5Ac. More recently, a series of partially O-acetylated Neu5Ac have been synthesized using regioselective exchange technology (ReSET) by the Gervay-Hague laboratory [13] . Taking advantage of the reactivity at various silyl ethers on Neu5Ac, ReSET generated mono-, di-, tri-, and tetra-O-acetylated Neu5Ac in a site-specific manner. Notably, Neu4,5Ac 2 was synthesized in four steps in a 19% yield with a 75% improved efficiency than the previous reported synthesis.

Step-economical methodologies such as ReSET can offer access to a divergent library of O-acetylated Neu5Ac in an efficient and pure form.

While chemical modifications of C 4 Sia have been reported elsewhere [145] [146] [147] [148] , advances in esterase tolerant, synthetically efficient, sialidase inhibitors could lead to a novel therapeutic without losing efficacy. Substitution of the O-acetyl group at the C 9 of Sia by an N-acetyl group minimized loss (or migration) of the acetyl group and retained a similar conformation as the O-ester. The authors argue that it can extend to other hydroxyl sites, including the C 4 in principle, which can serve as O-acetylated Neu5Ac surrogates that may display significant sialidase inhibition [149] .

Lead compounds can be generated using a rational drug design at the interface of synthetic chemistry, X-ray crystallography, and in silico studies. Particularly, blockades of Sia/sialidases hold tremendous therapeutic potential. Chemical modification at the C 4 of Sia, therefore, represents a unique, bio-inspired Sia variant that may be tailored to increase therapeutic efficacy of antiviral molecules.

Modified Sias, specifically O-acetylated isoforms, have been recognized as receptor determinants of virus pathogenesis. O-Acetylation is the most common form of post-glycosylation modification of Sias in mammalian cells. Mediated by specific SOATs, O-acetylation can occur at the C 4 or C 7-9 of Sias in a highly regulated and well-defined manner. Yet, structural elucidation of O-acetylated Sias remains incomplete and its biological implications have only recently garnered greater attention.

Modern extraction methods still remain a challenge to capture target molecules from a complex biological mixture in sufficient amounts. Methods to isolate site-specific O-acetylated sialic acids in high purity are needed. Given poor stability under current extraction techniques and spontaneous acetyl migrations that add to its structural complexity, synthetic access to O-acetylated Sias in high purity remains a valuable tool.

The discovery of O-acetylated Sias as major receptor determinants of virus pathogenesis provides a unique opportunity to develop therapeutics. Specifically, modifications at the C 4 may enhance sialidase inhibitor activities (Table 3) . Using chemical methodologies such as ReSET can be extended to install chemical groups tailored to improve efficacy. Furthermore, chemical handling of C 4 modifications would be much more feasible than C 7-9 modifications, since intramolecular complications such as acetyl migrations are scarce.

Different classes of viruses infect the host cell using glycoproteins (e.g., HA, HE, S, HEF) that aid in receptor binding or destroying functions. Most viral families, including Orthomyxoviridae, Paramyxoviridae, and Adenoviridae, utilize Sias on host membranes as recognition molecules for attachment and entry. However, only a subset of these human pathogens recognizes O-acetylated Sias, including influenza C, although studies related to this topic are currently under investigation. Moreover, recognition of O-acetylated isoforms appears to be site-specific. Taking this into account, C 4 of Neu5Ac represents a unique position for chemical modifications that could enable lead discoveries.

Funding: S.S.P. acknowledges support received through the Earl C. Anthony Fellowship (University of California, Davis).

Concerning the carbohydrate groups of submaxillary mucin. Hoppe-Seylers Zeitschrift fur Physiologische Chemie

Chemistry, metabolism, and biological functions of sialic acids

Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins

Shotgun glycomics of pig lung identifies natural endogenous receptors for influenza viruses

Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin

Receptor binding properties of human and animal H1 influenza virus isolates

Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates

Avian and human receptor binding by hemagglutinins of influenza A viruses

Receptor binding specificity of recent human H3N2 influenza viruses

Comparison of the receptor binding properties of contemporary swine isolates and early human pandemic H1N1 isolates (Novel 2009 H1N1)

Diversity in the sialic acids

Chemical diversity in the sialic acids and related α-keto acids: an evolutionary perspective

Synthesis of Partially O-Acetylated N-Acetylneuraminic Acid Using Regioselective Silyl Exchange Technology

Anomeric O-Functionalization of Carbohydrates for Chemical Conjugation to Vaccine Constructs

Functions and biosynthesis of o-acetylated sialic acids

Acetylated sialic acids and their role in immune defense

Metabolism and role of O-acetylated sialic acids

Identification of a sialate O-acetyltransferase from Campylobacter jejuni-Demonstration of direct transfer to the C-9 position of terminal α-2,8-linked sialic acid

Differences in the amount of N-acetyl-and N-glycoloyl-neuraminic acid, as well as O-acylated sialic acids, of fetal and adult bovine tissues

Subcellular Site of the Biosynthesis of O-Acetylated Sialic Acids in Bovine Submandibular-Gland

Functional and biosynthetic aspects of sialic acid diversity

Enzymatic 4-O-acetylation of N-acetylneuraminic acid in guinea-pig liver

Solubilisation and properties of the sialate-4-O-acetyltransferase from guinea pig liver

Characterization of the enzymatic 7-O-acetylation of sialic acids and evidence for enzymatic O-acetyl migration from C-7 to C-9 in bovine submandibular gland

Migration of O-Acetyl Groups in N,O-Acetylneuraminic Acids

Strucutres of the capsular polysaccharides of Neisseria meningitidis as determined by 13 C-nuclear magnetic resonance spectroscopy

Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines

Full 1 H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production

O-acetylation and de-O-acetylation of sialic acids. 7-and 9-O-acetylation of α-2,6-linked sialic acids on endogenous N-linked glycans in rat liver Golgi vesicles

Effects of Sialic Acid Modifications on Virus Binding and Infection

Influenza binds phosphorylated glycans from human lung

Viral and bacterial interactions in the upper respiratory tract

The co-pathogenesis of influenza viruses with bacteria in the lung

Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses

Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence

Unified theory of bacterial sialometabolism: how and why bacteria metabolize host sialic acids. ISRN Microbiol

Structural studies of 4-O-acetyl-α-N-acetylneuraminyl-(2→3)-lactose, the main oligosaccharide in echidna milk

4-O-acetyl-Nacetylneuraminic acid in the N-linked carbohydrate structures of equine and guinea pig α2-macroglobulins, potent inhibitors of influenza virus infection

Isolation and structures of glycoprotein-derived free sialooligosaccharides from the unfertilized eggs of Tribolodon hakonensis, a dace. Intracellular accumulation of a novel class of biantennary disialooligosaccharides

Carbohydrate structure analysis of batroxobin, a thrombin-like serine protease from Bothrops moojeni venom

O-acetylation of sialic acids

Analysis of monosaccharides, fatty constituents and rare O-acetylated sialic acids from gonads of the starfish Asterias rubens

Expression of the Infectious Salmon Anemia Virus Receptor on Atlantic Salmon Endothelial Cells Correlates with the Cell Tropism of the Virus

The in situ distribution of glycoprotein-bound 4-O-acetylated sialic acids in vertebrates

Determination of sialic acids

The release and purification of sialic acids from glycoconjugates: methods to minimize the loss and migration of O-acetyl groups

Identification and analysis of O-acetylated sialoglycoproteins

Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin

Molecular Microscopy of Brain Gangliosides: Illustrating their Distribution in Hippocampal Cell Layers

4-O-Acetyl-sialic acid (Neu4,5Ac2) in acidic milk oligosaccharides of the platypus (Ornithorhynchus anatinus) and its evolutionary significance

Specific distribution of sialic acids in animal tissues as examined by LC-ESI-MS after derivatization with 1,2-diamino-4,5-methylenedioxybenzene

High-performance liquid chromatography of N,O-acylated sialic acids

Determination of mono-O-acetylated N-acetylneuraminic acids in human and rat sera by fluorometric high-performance liquid chromatography

High-pressure liquid chromatography of sialic acids on a pellicular resin anion-exchange column with pulsed amperometric detection: a comparison with six other systems

A colorimetric assay to evaluate the chemotherapeutic response of children with acute lymphoblastic leukemia (ALL) employing achatininH: a 9-O-acetyl sialic acid binding lectin

Structural analysis of brain ganglioside acetylation patterns in mice with altered ganglioside biosynthesis

Colorimetry and Thin-Layer Chromatography of Sialic Acids

New sialic acids from biological sources identified by a comprehensive and sensitive approach: liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) of SIA quinoxalinones

Identification of O-acetylated N-acylneuraminic acids by mass spectrometry

High-resolution 1 H-NMR spectroscopy of free and glycosidically linked O-acetylated sialic acids

Characterization of sialic acids

Hydrolysis of sialic acids and O-acetylated sialic acids with propionic acid

Detection of sialic acids and gangliosides with special reference to 9-O-acetylated species in basaliomas and normal human skin

The histochemical demonstration of O-acylated sialic acid in gastrointestinal mucins. Their association with the potassium hydroxide-periodic acid-schiff effect

Fluorimetric determination of unsubstituted and 9(8)-O-acetylated sialic acids in erythrocyte membranes. Hoppe-Seyler's Zeitschrift fur Physiologische Chemie

An unique specificity of a sialic acid binding lectin AchatininH, from the hemolymph of Achatina fulica snail

The specificity of the binding site of AchatininH, a sialic acid-binding lectin from Achatina fulica

Identification of 9-O acetyl sialoglycoconjugates (9-OAcSGs) as biomarkers in childhood acute lymphoblastic leukemia using a lectin, AchatininH, as a probe

Physiochemical studies on achatininH, a novel sialic acid-binding lectin

Recombinant viral sialate-O-acetylesterases

Differential expression of sialylglycoconjugates and sialidase activity in distinct morphological stages of Fonsecaea pedrosoi

Studies on the specificity and sensitivity of the influenza C virus binding assay for 9-O-acetylated sialic acids and its application to human melanomas

Cell-surface sialoglycoconjugate structures in wild-type and mutant Crithidia fasciculata

Binding specificity of influenza C-virus to variably O-acetylated glycoconjugates and its use for histochemical detection of N-acetyl-9-O-acetylneuraminic acid in mammalian tissues

Modification of sialic acids by 9-O-acetylation is detected in human leucocytes using the lectin property of influenza C virus

9-O-acetylated sialic acids have widespread but selective expression: analysis using a chimeric dual-function probe derived from influenza C hemagglutinin-esterase

Use of influenza C virus for detection of 9-O-acetylated sialic acids on immobilized glycoconjugates by esterase activity

Selective inactivation of influenza C esterase: a probe for detecting 9-O-acetylated sialic acids

Analytical detection of 9(4)-O-acetylated sialoglycoproteins and gangliosides using influenza C virus

Infectious salmon anemia virus specifically binds to and hydrolyzes 4-O-acetylated sialic acids

Identification and characterization of viral structural proteins of infectious salmon anemia virus

The hemagglutinin-esterase of mouse hepatitis virus strain S is a sialate-4-O-acetylesterase

The sialate-4-O-acetylesterases of coronaviruses related to mouse hepatitis virus: A proposal to reorganize group 2 Coronaviridae

Nidovirus sialate-O-acetylesterases: evolution and substrate specificity of coronaviral and toroviral receptor-destroying enzymes

Structural basis for ligand and substrate recognition by torovirus hemagglutinin esterases

Hemagglutinating encephalomyelitis virus attaches to N-acetyl-9-O-acetylneuraminic acid-containing receptors on erythrocytes: comparison with bovine coronavirus and influenza C virus

Isolated HE-protein from hemagglutinating encephalomyelitis virus and bovine coronavirus has receptor-destroying and receptor-binding activity

Identification of a coronavirus hemagglutinin-esterase with a substrate specificity different from those of influenza C virus and bovine coronavirus

Structural and Functional-Analysis of the Surface Protein of Human Coronavirus OC43

Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus

The S protein of bovine coronavirus is a hemagglutinin recognizing 9-O-acetylated sialic acid as a receptor determinant

Bovine coronavirus uses N-acetyl-9-O-acetylneuraminic acid as a receptor determinant to initiate the infection of cultured cells

Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution

O-acetylation of a cell-surface carbohydrate creates discrete molecular patterns during neural development

CDw 60 antibodies bind to acetylated forms of ganglioside GD3

7-O-acetyl-GD3 in human T-lymphocytes is detected by a specific T-cell-activating monoclonal antibody

Variable region gene segments of nine monoclonal antibodies specific to disialogangliosides (GD2, GD3) and their O-acetylated derivatives

NeuA O-acetylesterase activity is specific for CMP-activated O-acetyl sialic acid in Streptococcus suis serotype 2

Effective one-pot multienzyme (OPME) synthesis of monotreme milk oligosaccharides and other sialosides containing 4-O-acetyl sialic acid

Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria

Structural Relationship between Sialic Acid, Neuraminic Acid and 2-Carboxy-Pyrrole

Sialic acids of horse serum with special reference to their virus inhibitory properties

Synthesis of 9-O-acetyl-and 4,9-di-O-acetyl derivatives of the methyl ester of N-acetyl-β-d-neuraminic acid methylglycoside. Their use as models in periodate oxidation studies. Hoppe-Seyler's Zeitschrift fur Physiologische Chemie

Studies on sialic acids. 19. Syntheses of partially O-acetylated 4-methylcoumarin-7-yl 5-acetamido-3,5-dideoxy-α-d-glycero-d-galacto-2-nonulopyranosidonic acids

Synthesis of fluorescent 7,8,9-tri-O-acetyl-N-acetylneuraminic acid and 4-O-acetyl-N-acetylneuraminic acid α-thioketosides

Regioselective acetylations of sialic acid α-ketosides

Synthesis of O-acetylated GM3s containing 9-O-acetyl sialic acid, containing, 4,9-di-O-acetyl sialic acid and containing 6'-O-acetyl galactose

Acetylneuraminic Acids and their Derivatives

Synthesis of the complete series of mono acetates of N-acetyl-d-neuraminic acid

Studies of naturally occurring modifications of sialic acids by fast-atom bombardment mass-spectrometry-Analysis of positional isomers by periodate cleavage

Isolation and characterization of novel O-acetylated GM3 containing 4-O-acetyl-N-acetyl sialic acid in equine erythrocytes

Molecular Dynamics Simulation Studies on Sialic acid and its Acetylated Derivatives and their Interaction with Vibrio Cholerae Neuraminidase

Influenza viruses differ in recognition of 4-O-acetyl substitution of sialic acid receptor determinant

Sialoglycoproteins of murine erythrocyte-ghosts-Modified periodic acid-schiff stain procedure staining non-substituted and O-acetylated sialyl residues on glycopeptides

Histoenzymological detection of sialic acids in the rodent salivary glands

Novel di-O-acetylated GM3s from equine erythrocytes, one containing 4,9-di-O-acetyl-N-glycolylneuraminic acid and another containing 4-O-acetyl-N-glycolylneuraminic acid and 6-O-acetyl-d-galactose

Demonstration of O-acetylated sialic acids in colonic epithelial glycoproteins

Chemical studies on a hamster sublingual glycoprotein

The Sialic Acids of Bovine and Equine Submaxillary mucins

Isolation and characterization of sialate 9(4)-O-acetylesterase from influenza C virus

Structural diversity in the α-2,8-linked polysialic acid chains in salmonid fish egg glycoproteins-occurrence of poly(Neu5Ac), poly(Neu5Gc), poly(Neu5Ac, Neu5Gc), poly(KDN), and their partially acetylated forms

Acid and enzymic hydrolysis of O-acetylated sialic acid residues from rabbit tamm-horsfall glycoprotein

Localisation and distribution of O-acetylated N-acetylneuraminic acids, the endogenous substrates of the hemagglutinin-esterases of murine coronaviruses, in mouse tissue

Isolation and properties of two sialate-O-acetylesterases from horse liver with 4-and 9-O-acetyl specificities

Can an ancestral condition for milk oligosaccharides be determined? Evidence from the Tasmanian echidna (Tachyglossus aculeatus setosus)

A neuraminidase from streptococcus sanguis that can release O-acetylated sialic acids

Isolation and characterization of an oligosaccharide specific and glycoprotein specific sialidase from human leukocytes. Hoppe-Seylers Zeitschrift fur Physiologische Chemie

4-methylumbelliferyl-α-glycosides of partially O-acetylated N-acetylneuraminic acids as substrates of a bacterial and viral sialidases

The action of sialidases on substrates containing O-acetylated sialic acids

Purification and properties of a Ca 2+ independent sialic acid binding lectin from human placenta with preferential affinity to ortho-acetylsialic acids

Basis for the potent inhibition of influenza virus infection by equine and guinea pig α2-macroglobulin

Sialate O-acetylesterases-Key enzymes in sialic acid catabolism

Metabolism of Ω-acyl-N-acetylneuraminic acids in bovine and equine submandibular glands

Members of a Novel Protein Family Containing Microneme Adhesive Repeat Domains Act as Sialic Acid-binding Lectins during Host Cell Invasion by Apicomplexan Parasites

The Murine Coronavirus Hemagglutinin-esterase Receptor-binding Site: A Major Shift in Ligand Specificity through Modest Changes in Architecture

Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells

Infectious salmon anaemia-Pathogenesis and tropism

Host tropism of infectious salmon anaemia virus in marine and freshwater fish species

Attachment of mouse hepatitis virus to O-acetylated sialic acid is mediated by hemagglutinin-esterase and not by the spike protein

Structure, function and evolution of the hemagglutinin-esterase proteins of corona-and toroviruses

Rational design of potent sialidase-based inhibitors of influenza virus replication

Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity

Why are Oseltamivir and Zanamivir effective against the newly emerged influenza A virus (A/H1N1

Strukturelle Abwandlungen an N-Acetylneuraminsäure, 2. Liebigs Ann. Der Chem

Synthesis of C-4-disubstituted analogues of N-acetylneuraminic acid

Synthesis and Biological Properties of N-Acetyl-4-deoxy-d-neuraminic Acid

Synthesis of 4-azido-4-deoxy-Neu5,7,8,9Ac42en1Me. A key intermediate for the synthesis of GG167 from d-glucono-delta-lactone

A Chemical Biology Solution to Problems with Studying Biologically Important but Unstable 9-O-Acetyl Sialic Acids

Acknowledgments: S.S.P. would like to acknowledge the two anonymous reviewers that provided insightful comments. S.S.P. would like to thank Professor Jacquelyn Gervay-Hague (University of California, Davis) for her thoughtful inputs and review.

The author declares no conflict of interest.